Autolus Therapeutics plc

NASDAQ:AUTL

Biotechnology

Healthcare
$1.09 +0.33%

+$0.01 today

Market cap
$290.12M
Beta
2.01
P/E (TTM)
-1.4
EPS (TTM)
-$1.09
52W Low $1.18High $2.70

Volume 2.10M

Average 1.60M

Price history

Autolus Therapeutics plc SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-15.50%

Period high

$2.54

Period low

$1.09

Latest

$1.09

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
S-8Nov 13, 2026Nov 13, 2026
SC 13G/ANov 12, 2026Nov 12, 2026
SC 13D/ANov 10, 2026Nov 10, 2026
8-KNov 10, 2026Nov 10, 2026
10-QNov 10, 2026Nov 10, 2026
EFFECTSep 22, 2026Sep 23, 2026
424B3Sep 22, 2026Sep 22, 2026
DEL AMSep 15, 2026Sep 15, 2026
S-3Sep 14, 2026Sep 11, 2026
4Sep 3, 2026Sep 3, 2026
SC 13D/AAug 28, 2026Aug 28, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
10-QAug 11, 2026Aug 11, 2026
8-KAug 11, 2026Aug 11, 2026
8-KAug 3, 2026Aug 3, 2026

Competitors

Who does Autolus Therapeutics plc compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about AUTL's filings, answered from its disclosures.

What is the latest AUTL filing?

The latest filing shown is S-8 dated Nov 13, 2026.

How many recent filings does AUTL have?

Intrinsic Alpha currently shows 20 recent filings for AUTL.